{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/124-US9,335,321(active).pdf"}, "page_content": "The method of claim 19, wherein cellular toxicity determined in a at least 100 teleosts.\n\nThe method of claim 1, wherein in the first tier are observed between 3 to 5 days post fertilization.\n\n21. The method of claim 1, wherein step (iii)(a) comprises determining the cardiotoxicity of agents in the teleost embryos.\n\n7. The method of claim 1, wherein the vascular system observed by staining endothelial cells with color substrates fluorescent substrates in fixed teleosts.\n\n22. The method of claim 21, wherein the teleost embryos at least 48 hour post fertilization.\n\n8. The method of claim 1, wherein the vascular system observed by injecting fluorescent substrates into the circula- system in live teleosts.\n\n23. The method of claim 21, wherein the cardiotoxicity parameters to be measured are heart rate and heart beat rhyth-\n\n9. The method of claim 1, wherein the vascular system observed by counting the number of intersegmental blood vessels, either totally from head to tail or in particular region, example the caudal region.\n\n24. The method of claim 21, wherein the cardiotoxicity parameter to be measured is caudal circulation.\n\nee Kk\n\nof\n\n6.\n\nthe\n\nteleosts\n\nis\n\nor\n\nis\n\ntion\n\nis\n\nfor\n\n10\n\n15\n\n20\n\n10.\n\nat time.\n\nthe\n\ndose\n\nis\n\norgans.\n\n19. effects cellular 20.\n\nadverse the\n\nis\n\nare\n\nmicity.\n\nat", "type": "Document"}}